Zensartan Beta 25mg/40mg Tablet PR 10s

Introduction to Zensartan Beta 25mg/40mg Tablet PR 10s

Zensartan Beta 25mg/40mg Tablet PR 10s is a pharmaceutical product in tablet form primarily used to manage high blood pressure and improve heart health. It combines two active ingredients, metoprolol succinate and telmisartan, to effectively control blood pressure and reduce cardiovascular risks.

Composition of Zensartan Beta 25mg/40mg Tablet PR 10s

This medication contains two main components: metoprolol succinate and telmisartan. Metoprolol succinate is a beta-blocker that works by slowing the heart rate and reducing its workload. Telmisartan is an angiotensin receptor blocker (ARB) that helps relax blood vessels, thereby lowering blood pressure.

Uses of Zensartan Beta 25mg/40mg Tablet PR 10s

• Treatment of high blood pressure (hypertension)
• Management of angina (chest pain)
• Reduction of heart failure symptoms
• Prevention of heart attacks and strokes

Side effects of Zensartan Beta 25mg/40mg Tablet PR 10s

• Common side effects: fatigue, dizziness, slow heart rate
• Serious side effects: severe low blood pressure, severe dizziness, fainting

Precautions of Zensartan Beta 25mg/40mg Tablet PR 10s

Patients with severe heart block, severe heart failure, or severe liver or kidney problems should avoid using this medication. Caution is advised for those with low blood pressure.

How to Take Zensartan Beta 25mg/40mg Tablet PR 10s

Take Zensartan Beta 25mg/40mg Tablet PR 10s orally as prescribed by your healthcare provider. The dosage may vary based on individual health conditions and response to treatment. Follow your doctor's instructions carefully.

Conclusion of Zensartan Beta 25mg/40mg Tablet PR 10s

Zensartan Beta 25mg/40mg Tablet PR 10s is a combination medication containing metoprolol succinate and telmisartan, used primarily for managing high blood pressure and improving heart health. Manufactured by COMPANYNAME, it belongs to the therapeutic class of beta-blockers and ARBs. This medication is essential for reducing cardiovascular risks and should be used under medical supervision.